NEW YORK, Dec. 9, 2015 /PRNewswire/ -- The following
statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise
acquired securities of Spectrum Pharmaceuticals, Inc. ("Spectrum
Pharmaceuticals") (NASDAQGS: SPPI) between May 7, 2015 and October
23, 2015.
You are hereby notified that a securities class action
lawsuit has been commenced in the United States District Court for
the District of Nevada. If you
purchased or otherwise acquired Spectrum Pharmaceuticals between
May 7, 2015 and October 23, 2015, your rights may be affected by
this action. To get more information go to:
http://zlk.9nl.com/spectrump or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
The complaint alleges that Spectrum Pharmaceuticals violated
federal securities laws by disseminating materially false and
misleading information and failing to disclose material facts,
causing the stock to trade at artificially inflated prices.
On October 23, 2015, Spectrum
announced that it has received a Complete Response Letter from the
U.S. Food and Drug Administration (FDA) in response to its New Drug
Application seeking clearance for Evomela, indicating that the FDA
cannot approve the application in its present form. Upon this news,
shares of Spectrum Pharmaceuticals fell more than 20% on intraday
trading.
If you suffered a loss in Spectrum Pharmaceuticals
you have until January 4, 2016
to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn't require that you serve as
a lead plaintiff.
Levi & Korsinsky is a national firm with offices in
New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have
extensive expertise and experience representing investors in
securities litigation involving financial fraud, and have recovered
hundreds of millions of dollars for aggrieved shareholders.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
Logo -
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/investor-alert-levi--korsinsky-llp-reminds-shareholders-of-spectrum-pharmaceuticals-inc-of-pendency-of-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-january-4-2016--sppi-300190744.html
SOURCE Levi & Korsinsky, LLP